Meeting/Event

Blending Clinical Practice and Research: Forging Partnerships to Enhance Drug Addiction Treatment

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA).
View current meetings on nida.nih.gov.

Details

to
Los Angeles, California

Contact

NIDA Clinical Trials Network

United States

Meeting Summary

2000 Meeting Overview:

The Blending Clinical Practice and Research: Forging Partnerships to Enhance Drug Addiction Treatment conference was held from November 1-2, 2000, in Los Angeles, California.  It provided an important opportunity for clinicians and researchers to examine cutting-edge scientific findings about drug abuse and addiction and the application of these findings to clinical practice, and to determine additional areas in need of research. The National Institute on Drug Abuse’s (NIDA) partners for this conference included: UCLA Integrated Substance Abuse Program, the Los Angeles County Alcohol and Drug Program Administration, and the Robert Wood Johnson Foundation.

The conference included a morning presentation by NIDA’s Director, Dr. Alan I. Leshner, regarding Putting Drug Abuse Research to Use in Real-Life Settings.  This was followed by a presentation on Bridging the Disconnect between Research and Practice, which discussed how the NIDA Clinical Trials Network (CTN) plans to take action.

Teams of clinicians and researchers then conducted workshops addressing the following topics:

  1. Drugs, the Brain, and Behavior
  2. Effectiveness of Treatment
  3. Innovations in Behavioral Therapy
  4. Innovations in Medications Development for Addiction
  5. Strategies for Working with Cultural Issues/Special Populations
  6. Co-Occurring Disorders
  7. Training Science-Based Treatment Principles
  8. Club Drugs: Effectiveness and Consequences
  9. Buprenorphine/Naloxone for Opiate Detox and Treatment
  10. Motivational Enhancement
  11. Motivational Incentives
  12. Medical Consequences of Drug Use
  13. Understanding Methadone and LAAM
  14. Adolescents and Drug Abuse: Treatment Perspectives
  15. Gender Issues in Treatment
  16. Methamphetamine Treatment

Agendas

Meeting Day 1

Begin End Session Faculty
9:00 a.m. 10:30 a.m. Presentation Alan I. Leshner, Ph.D.
10:30 a.m. 11:00 a.m. Morning Break
11:00 a.m. 12:15 p.m. Presentation
12:15 p.m. 1:15 p.m. Afternoon Break
1:15 p.m. 1:45 p.m. Research and Practice Gallery
1:45 p.m. 3:00 p.m. Concurrent Workshops A-H
3:00 p.m. 3:15 p.m. Break
3:15 p.m. 4:30 p.m. Concurrent Workshops I-P

Meeting Day 2

Begin End Session Faculty
8:30 a.m. 10:15 a.m. Welcome Patrick Ogawa
Nancy Kaufmann
Douglas Anglin
Forging Partnerships to Enhance Drug Treatment: Focus on Los Angeles
The Burden of Disease in Los Angeles Paul Simon, M.D., M.P.H.
The Drug Evaluation Network Survey: DENS Project Thomas McLellan, Ph.D.
Los Angeles County Evaluation System (LACES) Richard Rawson, Ph.D.
Douglas Anglin, Ph.D.
10:15 a.m. 10:45 a.m. Break
10:45 a.m. 12:00 p.m. Workshops A,F,H,N,O,P
Working Group- Forging Partnerships: Next Steps for Los Angeles
12:00 p.m. 1:00 p.m. Afternoon Break
1:00 p.m. 2:30 p.m. Forging Partnerships: Next Steps for Los Angeles Panel Discussion